Bibliotecas PUC-SP - Busca Integrada

The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

od Asim Amin, Asim Amin, Hans Hammers
Wydane w Frontiers in Immunology (2019-01-01)

Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists

od Sashi Debnath, Guiyang Hao, Bing Guan, Pawan Thapa, Justin Hao, Hans Hammers, Xiankai Sun
Wydane w International Journal of Molecular Sciences (2022-06-01)

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016

od Paolo A. Ascierto, Bruno Daniele, Hans Hammers, Vera Hirsh, Joseph Kim, Lisa Licitra, Rita Nanda, Sandro Pignata
Wydane w Journal of Translational Medicine (2017-10-01)

Acquired resistance to immune checkpoint therapy is caused by glycoprotein non-metastatic melanoma protein B signal cascade

od Jin-Sung Chung, Vijay Ramani, Lei Guo, Vinita Popat, Ponciano D. Cruz, Lin Xu, Hans Hammers, Kiyoshi Ariizumi
Wydane w Communications Medicine (2025-03-01)

Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma

od Raquibul Hannan, Alana Christie, Payal Kapur, James Brugarolas, Hans Hammers, Viral Patel, Roy Elias, Joseph Formella, William Schwartzman, Qi Cai, Venkat Malladi, Miguel Vazquez, Renee McKay, Ivan Pedrosa
Wydane w Journal for ImmunoTherapy of Cancer (2020-10-01)

Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance

od Jiajia Zhang, Franco Verde, Tricia Cottrell, Hans Hammers, Kellie N Smith, Janis Taube, Boyang Zhang, Genevieve J Kaunitz, Poromendro Burman, Hok-Yee Chan, Jody E Hooper, Mohamad E Allaf, Hongkai Ji
Wydane w Journal for ImmunoTherapy of Cancer (2021-07-01)

1017 SLAMF7+ CD8+ exhausted T cell-specific gene signature is associated with resistance to PD1 blockade in renal cell carcinoma

od Michael Hurwitz, Elizabeth Plimack, Jeffrey Sosman, Sabina Signoretti, David F McDermott, Michael B Atkins, Naomi B Haas, Hans Hammers, Nicholas Schindler, Opeyemi A Jegede, Catherine J Wu, David Braun, Miya Hugaboom, Kelly Street, Neil Ruthen, Lena Wirth
Wydane w Journal for ImmunoTherapy of Cancer (2023-11-01)

Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment

od Li Liu, Regan Schuetze, Jeni L. Gerberich, Ramona Lopez, Samuel O. Odutola, Rajendra P. Tanpure, Amanda K. Charlton-Sevcik, Justin K. Tidmore, Emily A.-S. Taylor, Payal Kapur, Hans Hammers, Mary Lynn Trawick, Kevin G. Pinney, Ralph P. Mason
Wydane w Cancers (2022-08-01)

Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor.

od Sushant K Kachhap, Nadine Rosmus, Spencer J Collis, Madeleine S Q Kortenhorst, Michel D Wissing, Mohammad Hedayati, Shabana Shabbeer, Janet Mendonca, Justin Deangelis, Luigi Marchionni, Jianqing Lin, Naseruddin Höti, Johan W R Nortier, Theodore L DeWeese, Hans Hammers, Michael A Carducci
Wydane w PLoS ONE (2010-06-01)

Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)

od Michael Hurwitz, Mark Stein, Jeffrey Sosman, David F McDermott, Michael B Atkins, Naomi B Haas, Elizabeth R Plimack, Hans Hammers, Mehmet A Bilen, Meredith M Regan, Moshe C Ornstein, David Einstein, Opeyemi A Jegede, Robert Alter, David J Peace, Paul J Catalano
Wydane w Journal for ImmunoTherapy of Cancer (2024-04-01)

Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy

od Osama Mohamad, Alberto Diaz de Leon, Samuel Schroeder, Andrew Leiker, Alana Christie, Elizabeth Zhang-Velten, Lakshya Trivedi, Saad Khan, Neil B Desai, Aaron Laine, Kevin Albuquerque, Puneeth Iyengar, Yull Arriaga, Kevin Courtney, David E. Gerber, Hans Hammers, Hak Choy, Robert Timmerman, James Brugarolas, Raquibul Hannan
Wydane w OncoImmunology (2018-07-01)

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)

od Brian I. Rini, Dena Battle, Robert A. Figlin, Daniel J. George, Hans Hammers, Tom Hutson, Eric Jonasch, Richard W. Joseph, David F. McDermott, Robert J. Motzer, Sumanta K. Pal, Allan J. Pantuck, David I. Quinn, Virginia Seery, Martin H. Voss, Christopher G. Wood, Laura S. Wood, Michael B. Atkins
Wydane w Journal for ImmunoTherapy of Cancer (2019-12-01)

Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)

od Alessia Cimadamore, Michael Hurwitz, Mark Stein, Sabina Signoretti, Jeffrey A Sosman, David F McDermott, Michael B Atkins, Naomi B Haas, Elizabeth R Plimack, Hans Hammers, Mehmet A Bilen, Moshe C Ornstein, David Einstein, Opeyemi A Jegede, Robert Alter, David J Peace, Thomas Denize, Catherine J Wu, David Braun, Paul J Catalano
Wydane w Journal for ImmunoTherapy of Cancer (2023-03-01)

Stereotactic Radiation Therapy for the Treatment of Glandular Metastases From Renal Cell Carcinoma

od Mihailo Miljanic, MD, Tidie Song, BS, Alana Christie, MS, Allen Yen, MD, Young Suk Kwon, MD, MPH, Aurelie Garant, MD, Todd A. Aguilera, MD, PhD, Zabihullah Wardak, MD, Hans Hammers, MD, Kevin Courtney, MD, PhD, Suzanne Cole, MD, James Brugarolas, MD, PhD, Robert Timmerman, MD, Raquibul Hannan, MD, PhD
Wydane w Advances in Radiation Oncology (2025-09-01)

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma

od Michael B. Atkins, David F. McDermott, David I. Quinn, Thomas Olencki, Thomas Hutson, Brian I. Rini, Laura S. Wood, Martin H. Voss, Hans Hammers, William Bro, Ronald M. Bukowski, Bernard Faba, Jo Faba, Robert A. Figlin, Eric Jonasch, Richard W. Joseph, Bradley C. Leibovich, Allan J. Pantuck, Virginia Seery, Christopher G. Wood
Wydane w Journal for ImmunoTherapy of Cancer (2016-12-01)

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma

od Jonathan E. Schoenhals, BS, Osama Mohamad, MD, PhD, Alana Christie, MS, Yuanyuan Zhang, MD, PhD, Daniel Li, MD, Nirmish Singla, MD, MSCS, Isaac Bowman, MD, Waddah Arafat, MD, Hans Hammers, MD, Kevin Courtney, MD, PhD, Suzanne Cole, MD, Aditya Bagrodia, MD, Vitaly Margulis, MD, Neil Desai, MD, Aurelie Garant, MD, Hak Choy, MD, Robert Timmerman, MD, James Brugarolas, MD, PhD, Raquibul Hannan, MD, PhD
Wydane w Advances in Radiation Oncology (2021-09-01)

Extracranial Palliative Radiation Therapy for Renal Cell Carcinoma

od Young Suk Kwon, MD, MPH, Eric Hsu, MD, PhD, Maggie Stein, BSPH, Alana Christie, MS, Aurelie Garant, MD, Neil B. Desai, MD, Andrew Wang, MD, Daniel X. Yang, MD, Allen Yen, MD, Mihailo Miljanic, MD, Kevin D. Courtney, MD, PhD, Hans Hammers, MD, PhD, Tian Zhang, MD, Waddah Arafat, MD, Qian Qin, MD, Suzanne Cole, MD, James Brugarolas, MD, PhD, Robert Timmerman, MD, Raquibul Hannan, MD, PhD
Wydane w Advances in Radiation Oncology (2025-10-01)